My name is Thomas Schrauwen, I have four years of industry experience in stem cell biology, molecular engineering, and computational biology. In 2024, I started a MSc in Molecular Genetics & Biotechnology in combination with my full-time job in the cultivated meat sector. Currently, I am applying generative AI for de novo nanobody design against migraine-associated GPCRs at DTU Denmark, combining deep wet-lab expertise with data-driven approaches to therapeutic discovery.

Technical University of Denmark (DTU) · Dept. of Bioengineering · Mar 2026 – Present · Kongens Lyngby, Denmark

Supervised by Dr. Timothy Jenkins

• Designing de novo nanobodies against migraine-associated GPCRs using generative AI, integrating protein language models and structure-based deep learning for candidate generation and in silico and in vitro evaluation.

Institute of Biology Leiden (IBL), Leiden University · Jan 2025 – Jul 2025 · Leiden, Netherlands

Supervised by Prof. Marcel Schaaf and Dr. Bastienne Vriesendorp · 8.5/10

• Performed scRNA-seq analysis in R (Seurat, Bioconductor) to characterise glucocorticoid-induced transcriptional responses in zebrafish.
• Conducted protein-ligand docking on an HPC cluster (Linux, Slurm, Conda) to predict novel glucocorticoid receptor-binding candidates.

Meatable · Mar 2023 – Nov 2025 · Leiden, Netherlands

• Cultured porcine and bovine cell lines — primary cells, iPSCs, and EpiSCs — across 2D and 3D suspension formats (shaker flasks, 96-well plates, Ambr250 bioreactors).
• Executed RNA- and DNA-based reprogramming experiments, characterising newly derived lines from induction to stable establishment using molecular and imaging assays.
• Designed plasmid constructs in SnapGene and Benchling for cloning workflows.
• Led a project establishing a high-throughput screening workflow for 3D stem cell aggregates in suspension, achieving 20× greater throughput for media development and cell line adaptation.

Cell Culture Technician · Mar 2022 – Mar 2023

Centre for Medical Genetics, University of Antwerp · Feb 2021 – May 2021 · Antwerp, Belgium

• Contributed to optimising a CRISPR/Cas9 workflow for introducing pathogenic Brugada Syndrome mutations into hiPSCs.
• Screened gRNA candidates via nucleofection to identify optimal InDel-forming sequences, confirmed by Sanger sequencing and gel electrophoresis.
• Techniques: gRNA design, nucleofection, PCR, Sanger sequencing, gel electrophoresis, DNA/RNA isolation, mycoplasma detection.

Dutch — Native   English — Fluent   French — Intermediate